ODG
LFMD icon

O'Dell Group’s LifeMD LFMD Stock Holding History

O'Dell Group’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-300
Closed -$1.3K – 293
2023
Q2 		$1.3K Buy
+300
New +$666 ﹤0.01% 453
2022
Q2 		– Sell
-300
Closed -$1K – 512
2022
Q1 		$1K Hold
300
– – ﹤0.01% 485
2021
Q4 		$1K Hold
300
– – ﹤0.01% 489
2021
Q3 		$2K Buy
+300
New +$2.56K ﹤0.01% 438

Other funds holding LFMD

DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

O'Dell Group's LFMD Position: Q3 2023 in Review

O'Dell Group sold out of LifeMD (LFMD) in Q3 2023, closing a stake of 300 shares — an estimated $1.3K sold.

O'Dell Group first reported a position in LFMD in Q3 2021 and held it in 4 quarters. The position peaked at $2K in Q3 2021. 62 funds tracked by Wall St. Rank hold LFMD as of Q3 2023.

  • O'Dell Group reported no remaining LifeMD position as of Q3 2023 after selling out during the quarter.
  • O'Dell Group sold 300 LifeMD shares in Q3 2023, an estimated $1.3K.
  • O'Dell Group first reported a position in LifeMD in Q3 2021 and held it in 4 quarters.
  • O'Dell Group's LifeMD position peaked at $2K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held LifeMD as of Q3 2023.

Based on O'Dell Group's 13F filing for Q3 2023, filed 13 Nov 2023.